Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
13181
-
13182
-
13183
-
13184
Raw data used for graph (related to Fig 1).
Published 2024“…We used MCF7 as functional estrogen and non-invasive and MDA-MB-231 cell lines as triple-negative type of breast cancer and a model for more aggressive.…”
-
13185
-
13186
-
13187
-
13188
-
13189
Integrin β4, αV, α5 and β3, were differentially regulated among the three cell lines in response to glucose.
Published 2014“…Integrin α-V was significantly decreased under hypoglycemia only in MDA-MB-231P cells p = 0.001. …”
-
13190
Data_Sheet_1_v1_Role of Female Research at the Asociacion Mexicana de Cirugia General Annual Meeting: A Retrospective Analysis From 2013 to 2019.pdf
Published 2022“…The percentage of females’ abstracts selected for oral presentation was less than the percentage of males’ 49 abstracts selected for presentation (9% vs. 11.5%; p = 0.002). Females’ abstracts submitted have a 50 23.5% decreased chance of being selected for oral presentation (OR = 0.765, CI 95%, 0.639–0.917, 51 p = 0.003). …”
-
13191
Data_Sheet_1_v1_Role of Female Research at the Asociacion Mexicana de Cirugia General Annual Meeting: A Retrospective Analysis From 2013 to 2019.pdf
Published 2022“…The percentage of females’ abstracts selected for oral presentation was less than the percentage of males’ 49 abstracts selected for presentation (9% vs. 11.5%; p = 0.002). Females’ abstracts submitted have a 50 23.5% decreased chance of being selected for oral presentation (OR = 0.765, CI 95%, 0.639–0.917, 51 p = 0.003). …”
-
13192
-
13193
-
13194
-
13195
A PKR inhibitor also inhibits DDK activity and induces apoptosis in breast cancer cells.
Published 2014“…<p>IC<sub>50</sub> values for the PKR inhibitor (shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0113300#pone-0113300-g007" target="_blank">Figure 7</a>) were determined against purified DDK (<b>A</b>) and HCC1954 cells (<b>B</b>). …”
-
13196
-
13197
Image_3_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif
Published 2022“…Next with the largest cohort of patients with DNMT3A R882 mutant MDS known to date from multiple institutions, DNMT3A R882 mutant MDS cases were shown to have more severe leukopenia, enriched SRSF2 and IDH2 mutations, increased cases with excess blasts (47% vs 22.5%, p=.004), markedly increased risk of AML transformation (25.8%, vs. 1.7%, p=.0001) and a worse progression-free survival (PFS) (median 20.3, vs. >50 months, p=.009) than non-R882 mutant MDS cases. …”
-
13198
Image_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif
Published 2022“…Next with the largest cohort of patients with DNMT3A R882 mutant MDS known to date from multiple institutions, DNMT3A R882 mutant MDS cases were shown to have more severe leukopenia, enriched SRSF2 and IDH2 mutations, increased cases with excess blasts (47% vs 22.5%, p=.004), markedly increased risk of AML transformation (25.8%, vs. 1.7%, p=.0001) and a worse progression-free survival (PFS) (median 20.3, vs. >50 months, p=.009) than non-R882 mutant MDS cases. …”
-
13199
Crystal Structure of YbCu<sub>6</sub>In<sub>6</sub> and Mixed Valence Behavior of Yb in YbCu<sub>6–<i>x</i></sub>In<sub>6+<i>x</i></sub> (<i>x</i> = 0, 1, and 2) Solid Solution
Published 2016“…YbCu<sub>6</sub>In<sub>6</sub> crystallizes in the CeMn<sub>4</sub>Al<sub>8</sub> structure type, tetragonal space group <i>I</i>4/<i>mmm</i>, and the lattice constants are <i>a</i> = <i>b</i> = 9.2200(13) Å and <i>c</i> = 5.3976(11) Å. …”
-
13200
Image_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif
Published 2022“…Next with the largest cohort of patients with DNMT3A R882 mutant MDS known to date from multiple institutions, DNMT3A R882 mutant MDS cases were shown to have more severe leukopenia, enriched SRSF2 and IDH2 mutations, increased cases with excess blasts (47% vs 22.5%, p=.004), markedly increased risk of AML transformation (25.8%, vs. 1.7%, p=.0001) and a worse progression-free survival (PFS) (median 20.3, vs. >50 months, p=.009) than non-R882 mutant MDS cases. …”